Healthcare, Pharma & Life Sciences

Armata Gets $3.7M DoW Funding, Total Hits $32.4M for Phage Therapy

Image
Armata Gets $3.7M DoW Funding, Total Hits $32.4M for Phage Therapy

Los Angeles – September 24, 2026 -- Armata Pharmaceuticals has received an additional $3.7 million in non-dilutive funding from the U.S. Department of War, pushing cumulative government support for its lead bacteriophage candidate AP-SA02 to approximately $32.4 million.

New funds mark first Phase 3-specific allocation under existing DoW award

The $3.7 million tranche represents the first capital earmarked specifically for Phase 3 execution under a previously announced award, following $28.7 million already disbursed. The funding flows through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command's Naval Advanced Medical Development unit, with backing from the Defense Health Agency and Joint Warfighter Medical Research Program.

Ping An Good Doctor Links AI to Human Care Networks in China

Hong Kong – September 24, 2026 -- Ping An Good Doctor (HKEX: 1833) said its AI business accounted for approximately 4.6% of gross profit in the first half of 2026, as the Hong Kong-listed insurer's healthcare arm shifts from diagnostic AI tools toward services that execute care plans on the ground.

Ping An launches AI-powered home rehab coaching

The company upgraded its Ping An AI Doctor service with Ping An Smart Private Coach, a hybrid AI-and-coaching offering that tracks 34 points on the body to deliver real-time feedback across seven categories, including posture correction, chronic-pain rehabilitation, postpartum recovery and Baduanjin qigong exercise. The global market for AI personal trainers is projected to grow from $16.9 billion in 2025 to $65.7 billion by 2033, a trend coinciding with China's National Health Commission "Weight Management Year" initiative launched in 2024.

CSA Medical's RejuvenAir Cuts Severe COPD Exacerbations 38.4% in Pivotal Trial

Image
CSA Medical's RejuvenAir Cuts Severe COPD Exacerbations 38.4% in Pivotal Trial

Boston – September 24, 2026 -- CSA Medical, Inc. announced publication in the American Journal of Respiratory and Critical Care Medicine of pivotal SPRAY-CB trial results showing its RejuvenAir System reduced severe COPD exacerbation rates by 38.4% versus a sham control.

Trial enrolled 210 patients across the US and UK despite optimal medical therapy

The randomized, blinded, sham-controlled SPRAY-CB trial (NCT03893370) tested Metered CryoSpray (MCS) therapy in patients with moderate-to-severe COPD and symptomatic chronic bronchitis who remained highly symptomatic despite receiving standard-of-care medication.

Minnesota Dental Association Installs 2026-2027 Officers, Trustees

MINNEAPOLIS – September 24, 2026 -- The Minnesota Dental Association (MDA) installed six new officers and two new trustees during its Leadership Conference on September 18 in Shoreview, formally launching the 2026-2027 governance term.

Dr. John Noack takes over as MDA president for the 2026-2027 term.

Dr. Noack, of Professional Dental Group in Northfield, assumes the top leadership post. Dr. Aruna Rao of Koala Dental Care in St. Cloud was installed as president-elect, positioning her to succeed Noack next term.

Five additional officers complete the new executive slate.

Dr. Loren Taple of Northwood Dental in Eagan was named first vice president, and Dr. Nathan Pedersen of Dental Health Service in Hibbing was named second vice president. Dr. Brandon Ulstad of Madison Dental Clinic in Madison will serve as Speaker of the House, while Dr. Alejandro Aguirre of Plymouth was appointed treasurer.

AdminaHealth Rolls Out Read-Only AI Assistant for Enterprise Billing Data

Image
AdminaHealth Rolls Out Read-Only AI Assistant for Enterprise Billing Data

Greenwich, Conn. – September 24, 2026 -- AdminaHealth has launched an AI-powered data assistant for Enterprise customers of its Billing Suite, letting users query billing, enrollment, and reconciliation data using plain-language questions instead of navigating reports screen by screen.

Assistant answers billing queries directly from workspace records

Users can ask what a group's bill totaled for a given month, where a mid-period adjustment originated, or which member's coverage changed, and receive a direct answer drawn from that workspace's data.

Apex Dental Partners Lands Eighth Straight Inc. 5000 Ranking

Dallas – September 24, 2026 -- Apex Dental Partners has been named No. 3,850 on the Inc. 5000 list of America's fastest-growing private companies, marking its eighth consecutive year on the ranking after posting 67% revenue growth over the past three years.

Apex secures its eighth straight Inc. 5000 placement on sustained revenue growth

The Dallas-based dental partnership organization, which supports dentists and affiliated practices, achieved the 67% three-year revenue growth figure that placed it at No. 3,850 on the annual list published by Inc. magazine. The Inc. 5000 ranks privately held U.S. companies strictly by percentage revenue growth over a three-year period, making Apex's eight consecutive appearances a marker of consistent expansion in the fragmented dental services sector.

Genzeon Wins UiPath 2026 Healthcare Industry Impact Partner Award

Image
Genzeon Wins UiPath 2026 Healthcare Industry Impact Partner Award

Las Vegas – September 24, 2026 -- Genzeon has been named UiPath's 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences, recognizing five years of joint automation work that has processed hundreds of thousands of healthcare transactions annually.

The award was presented at UiPath FUSION 2026 and cited Genzeon's role in converting AI and robotic process automation into measurable financial and operational outcomes for payers, providers and life sciences clients.

Prior authorization platform handles 450,000 cases annually under CMS mandate

For the CMS WISeR program, Genzeon and UiPath built prior authorization infrastructure processing more than 450,000 cases per year across 17 high-risk service categories. The system automates 85% to 90% of routine determinations while meeting mandatory 72-hour turnaround windows and complying with FHIR and CMS-0057-F requirements.

LaserAway Opens 232nd Clinic in Lubbock, Marks 20 Years, Zero Closures

Image
LaserAway Opens 232nd Clinic in Lubbock, Marks 20 Years, Zero Closures

Los Angeles – – September 24, 2026 -- LaserAway has opened its 232nd U.S. clinic in Lubbock, Texas, extending a 20-year run without a single location closure since its 2006 founding.

Lubbock clinic expands LaserAway's footprint to 36 states

The new site at 4210 82nd St, #206, Lubbock, TX 79423, will offer laser hair removal, Botox, dermal fillers, skin rejuvenation, and body contouring treatments including CoolSculpting and Thermage. It will also add LaserAway Wellness Injections administered by licensed medical staff.

Company scales from one West Hollywood clinic to 232 locations

LaserAway was founded in 2006 by Dr. Roy Winston and brothers Scott, Brock, and Todd Heckmann, starting with a single clinic on Sunset Boulevard in West Hollywood, CA. The company remains privately owned and operated, with no franchised locations, and now operates across 36 states.

Drones Deliver Freeze-Dried Plasma to Ukraine's Front-Line Wounded

Image
Drones Deliver Freeze-Dried Plasma to Ukraine's Front-Line Wounded

Aurora, Colo. – September 24, 2026 -- Researchers at the University of Colorado Anschutz report a 100% 24-hour survival rate among 26 Ukrainian military personnel who received drone-delivered freeze-dried plasma at the point of injury, a preliminary finding from an ongoing study testing whether unmanned aircraft can bring blood products to critically injured patients before conventional evacuation reaches them.

Drones carry Octapharma-donated plasma to front-line medics in Ukraine

The freeze-dried plasma, donated by global pharmaceutical company Octapharma, is packaged for transport and flown by drone to medical teams operating near the point of injury. Unlike fresh frozen plasma, which requires freezing and thawing, the freeze-dried version can be stored at room temperature and prepared rapidly for administration, addressing a logistical barrier the FDA has identified for battlefield, remote and disaster settings.

Oracle Launches AI-Powered Oncology EHR for Cancer Care Teams

Image
Oracle Launches AI-Powered Oncology EHR for Cancer Care Teams

Orlando, Fla. – September 24, 2026 -- Oracle unveiled Oracle Health Oncology EHR, a new ambulatory electronic health record system purpose-built for cancer care, combining oncology-specific workflows with AI-driven clinical intelligence at the Oracle Health and Life Sciences Summit.

Oracle targets fragmented oncology data with unified patient timelines

The platform is designed to consolidate cancer diagnoses, chemotherapy regimens, laboratory and imaging results, medications, referrals, and insurance requirements into a single chronological record spanning inpatient and outpatient settings. Oracle states that fragmented information currently forces clinicians to spend time reassembling patient context while patients repeatedly recount their medical history across care settings.